• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管重塑与激肽释放酶-激肽系统

Vascular remodeling and the kallikrein-kinin system.

作者信息

Carretero Oscar A

机构信息

Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Michigan 48202, USA.

出版信息

J Clin Invest. 2005 Mar;115(3):588-91. doi: 10.1172/JCI24567.

DOI:10.1172/JCI24567
PMID:15765142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1052021/
Abstract

Remodeling of the arterial wall occurs mainly as a consequence of increased wall stress caused by hypertension. In this issue of the JCI, Azizi et al. report that in humans with a kallikrein gene polymorphism that lowers kallikrein activity, the brachial artery undergoes eutrophic inward remodeling in the absence of hypertension or other hemodynamic changes. It has also been reported that alterations of the kallikrein-kinin system are associated with formation of aortic aneurysms. Conversely, after vascular injury, kinins mediate the beneficial effect of angiotensin-converting enzyme inhibitors that prevent neointima formation. These findings raise the intriguing possibility that decreased kallikrein-kinin system activity may play an important role in the pathogenesis of vascular remodeling and disease, while increased activity may have a beneficial effect.

摘要

动脉壁重塑主要是由高血压引起的壁应力增加所致。在本期《临床研究杂志》中,阿齐兹等人报告称,在携带降低激肽释放酶活性的激肽释放酶基因多态性的人类中,肱动脉在无高血压或其他血流动力学变化的情况下会发生营养性内向重塑。也有报道称,激肽释放酶-激肽系统的改变与主动脉瘤的形成有关。相反,血管损伤后,激肽介导血管紧张素转换酶抑制剂预防内膜增生的有益作用。这些发现提出了一个有趣的可能性,即激肽释放酶-激肽系统活性降低可能在血管重塑和疾病的发病机制中起重要作用,而活性增加可能具有有益作用。

相似文献

1
Vascular remodeling and the kallikrein-kinin system.血管重塑与激肽释放酶-激肽系统
J Clin Invest. 2005 Mar;115(3):588-91. doi: 10.1172/JCI24567.
2
The renal kallikrein-kinin system at the prehypertensive stage of hypertension.
Agents Actions Suppl. 1992;38 ( Pt 3):287-93.
3
Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.疾病机制:高血压与血管重塑中的组织激肽释放酶-激肽系统
Nat Clin Pract Nephrol. 2007 Apr;3(4):208-21. doi: 10.1038/ncpneph0444.
4
Role of kinins and prostacyclin in blood pressure regulation.激肽和前列环素在血压调节中的作用。
Arch Mal Coeur Vaiss. 1989 Nov;82 Spec No 4:15-9.
5
Release of endothelial-derived kallikrein, kininogen and kinins.内皮源性激肽释放酶、激肽原和激肽的释放。
Biol Res. 1998;31(3):169-74.
6
The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis.急性胰腺炎手术患者和非手术患者中的激肽释放酶-激肽系统
Acta Chir Scand. 1985;151(4):371-5.
7
The kallikrein/kinin system in ocular function.眼功能中的激肽释放酶/激肽系统。
J Ocul Pharmacol Ther. 2011 Dec;27(6):539-43. doi: 10.1089/jop.2011.0187. Epub 2011 Dec 2.
8
Interference of converting enzyme inhibitors with the kallikrein-kinin system.转化酶抑制剂对激肽释放酶-激肽系统的干扰。
Clin Exp Hypertens A. 1983;5(7-8):1277-85. doi: 10.3109/10641968309048857.
9
Endocrine mechanisms in the pathogenesis of essential hypertension. III. Special reference on the interrelations between the prostaglandin and kallikrein-kinin systems.
Physiologie. 1981;18(2):141-52.
10
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.激肽在血管紧张素转换酶抑制剂心血管作用中的贡献。
Pharmacol Rev. 1995 Mar;47(1):25-49.

引用本文的文献

1
Genetic and Epigenetic Mechanisms Underlying Vascular Smooth Muscle Cell Phenotypic Modulation in Abdominal Aortic Aneurysm.腹主动脉瘤中血管平滑肌细胞表型调节的遗传和表观遗传机制。
Int J Mol Sci. 2020 Aug 31;21(17):6334. doi: 10.3390/ijms21176334.
2
Unleashing the therapeutic potential of human kallikrein-related serine proteases.释放人激肽释放酶相关丝氨酸蛋白酶的治疗潜力。
Nat Rev Drug Discov. 2015 Mar;14(3):183-202. doi: 10.1038/nrd4534. Epub 2015 Feb 20.
3
Detection of renal tissue and urinary tract proteins in the human urine after space flight.载人航天飞行后尿液中肾组织和尿路上皮细胞蛋白的检测。
PLoS One. 2013 Aug 13;8(8):e71652. doi: 10.1371/journal.pone.0071652. eCollection 2013.
4
Cellular mediators of renal vascular dysfunction in hypertension.高血压中肾血管功能障碍的细胞介质
Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1001-18. doi: 10.1152/ajpregu.90960.2008. Epub 2009 Feb 18.
5
Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.脯氨酰羧肽酶参与吴茱萸次碱对肾血管性高血压大鼠肠系膜动脉肥厚消退的作用。
Clin Exp Pharmacol Physiol. 2009 Mar;36(3):319-24. doi: 10.1111/j.1440-1681.2008.05079.x. Epub 2008 Oct 31.

本文引用的文献

1
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.人类组织激肽释放酶活性部分基因缺陷的动脉和肾脏后果。
J Clin Invest. 2005 Mar;115(3):780-7. doi: 10.1172/JCI23669.
2
Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis.
Physiol Genomics. 2004 Sep 16;19(1):41-9. doi: 10.1152/physiolgenomics.00035.2004. Epub 2004 Jul 6.
3
Role of tissue kallikrein in response to flow in mouse resistance arteries.组织激肽释放酶在小鼠阻力动脉血流反应中的作用。
J Hypertens. 2004 Apr;22(4):745-50. doi: 10.1097/00004872-200404000-00017.
4
Inward remodeling follows chronic vasoconstriction in isolated resistance arteries.
J Vasc Res. 2002 Jan-Feb;39(1):12-20. doi: 10.1159/000048989.
5
Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice.组织激肽释放酶基因敲除小鼠颈动脉中血流依赖性扩张减弱。
Circ Res. 2001 Mar 30;88(6):593-9. doi: 10.1161/01.res.88.6.593.
6
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.组织激肽释放酶缺陷小鼠中血压正常的心血管异常。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2634-9. doi: 10.1073/pnas.051619598. Epub 2001 Feb 20.
7
Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors.高盐摄入对缺乏缓激肽B2受体的突变小鼠的影响。
Hypertension. 1997 Jan;29(1 Pt 2):483-7. doi: 10.1161/01.hyp.29.1.483.
8
Vascular remodeling.血管重塑
Hypertension. 1996 Sep;28(3):505-6.
9
Role of nitric oxide in the effect of blood flow on neointima formation.一氧化氮在血流对新生内膜形成影响中的作用。
J Vasc Surg. 1996 Feb;23(2):314-22. doi: 10.1016/s0741-5214(96)70276-8.
10
Vascular kallikrein in deoxycorticosterone acetate-salt hypertensive rats.脱氧皮质酮醋酸盐-盐性高血压大鼠中的血管激肽释放酶
Hypertension. 1994 Jan;23(1 Suppl):I185-8. doi: 10.1161/01.hyp.23.1_suppl.i185.